Background: Several chronic inflammatory diseases are associated with cardiovascular disease, but the cardiovascular risk in ANCA-associated vasculitis is poorly quantified. Objectives: The aim of the present study is to review the evidence for the increased cardiovascular risk in patients with ANCA-associated vasculitis. Methods: A comprehensive systematic review was conducted in accordance with guidelines of preferred reporting items for systematic reviews and meta-analyses (PRISMA). The databases PubMed, Embase.com and the Cochrane Library (Wiley) were searched for original observational studies reporting an estimate of the association between ANCA-associated vasculitis and cardiovascular events, including ischemic heart disease, cerebrovascular accidents and/or peripheral arterial disease. The quality of the included studies was assessed with the Newcastle-Ottawa Scale. Summary estimates were derived with a randomeffects model and reported as relative risks. Results: 1375 studies were identified and 7 studies were included comprising 14098 ANCA-associated vasculitis patients versus general population controls in 6 studies and chronic kidney disease patients in 1 study. ANCA-associated vasculitis carried a relative risk of 1.65 (95% confidence interval, 1.23-2.22) for all cardiovascular events, 1.60 (1.39-1.84) for ischemic heart disease and 1.20 (0.98-1.48) for cerebrovascular accidents. We did not find studies that addressed the risk for peripheral arterial disease separately. No heterogeneity was seen in the estimates.
FRI0310 LONG-TERM MORTALITY AND COMPLICATIONS IN YOUNG AND ELDERLY PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
Background: Advancing age is a risk factor for complications and mortality in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
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Objectives: To analyze differences in infectious, metabolic and cardiovascular complications, renal function, and mortality in patients diagnosed with AAV before or after 65 years of age, and followed for up to 5 years. Figure  1 ), mirrored by a higher annual severe infection rate (p=0.041; 0.22±0.69 versus 0.05±0.17) and annual mortality rate (p=0.001; 0.33±1.02 versus 0.01±0.08) in EP group. Relapse rate was similar in YP and EP within 5 years (Figure 1 ). Lymphopenia rate (at least 1 event, <1000x10 9 /L) was significantly higher in EP only at 6 month (p<0.05), whereas severe lymphopenia (<500x10 9 /L), leukopenia (<4000x10 9 /L) or hypogammaglobinemia (Ig<5g/L) rates were similar in both groups during the follow-up. Persistent lymphopenia (≥12months, <1000x10 9 /L) was detected in 3 patients after cyclophosphamide treatment (2 YP and 1 EP). Only relapse before 2 years of follow-up was associated with infections in YP (p<0.001, OR 4.0 [CI 95%, 1.2-13.3]), but not in EP. Conclusions: Heart failure is more frequent in older patients, which have higher infection and mortality rates. Transient lymphopenia is significantly higher in EP after induction treatment, but is not associated with their increase in infectious events. Despite a similar incidence of relapse in YP and EP, relapsing disease associates with infectious events in YP, but not in EP. Background: Although medical treatment has advanced, surgical treatment is needed to control the progression and symptoms of Takayau arteritis (TA). Endovascular intervention or surgical revascularization is performed; however, there are few comparative studies of these methods. Objectives: There are many studies about surgery and endovascular intervention; however, it is still unclear which treatment has better a benefit/risk ratio. Because neither meta-analysis nor large-scale studies are available for surgical treatment of TA, we conducted a meta-analysis to examine the outcome of surgical treatment. Methods: A meta-analysis comparing endovascular intervention and surgery outcomes was performed using the MEDLINE and Embase databases. Results: A total of 14 studies of 598 patients and 1,049 lesions were included. Endovascular intervention was performed in 418 lesions and surgery in 631 lesions. Restenosis was more common in endovascular intervention than in surgery (odds ratio [OR] Conclusions: This meta-analysis showed the superiority of surgical revascularization over endovascular intervention.
